Last updated on June 2019

Study of the Efficacy Safety and Tolerability of Serlopitant for the Treatment of Chronic Pruritus of Unknown Origin


Brief description of study

A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Chronic Pruritus of Unknown Origin

Clinical Study Identifier: NCT03841331

Find a site near you

Start Over

Study Site 221

Hot Springs, AR United States
  Connect »

Study Site 823

Bakersfield, CA United States
  Connect »

Study Site 204

Fremont, CA United States
  Connect »

Study Site 803

Los Angeles, CA United States
  Connect »

Study Site 820

Centennial, CO United States
  Connect »

Study Site 804

Denver, CO United States
  Connect »

Study Site 811

Aventura, FL United States
  Connect »

Study Site 801

Jacksonville, FL United States
  Connect »

Study Site 807

Miami, FL United States
  Connect »

Study Site 331

Miami, FL United States
  Connect »

Study Site 824

Sarasota, FL United States
  Connect »

Study Site 818

West Palm Beach, FL United States
  Connect »

Study Site 349

Savannah, GA United States
  Connect »

Study Site 814

Indianapolis, IN United States
  Connect »

Study Site 808

Brighton, MA United States
  Connect »

Study Site 822

Rolla, MO United States
  Connect »

Study Site 371

Saint Joseph, MO United States
  Connect »

Study Site 821

Bellevue, NE United States
  Connect »

Study Site 813

Las Vegas, NV United States
  Connect »

Study Site 387

Las Vegas, NV United States
  Connect »

Study Site 816

Morristown, NJ United States
  Connect »

Study Site 121

Ocean Township, NJ United States
  Connect »

Study Site 802

Bronx, NY United States
  Connect »

Study Site 507

Brooklyn, NY United States
  Connect »

Study Site 341

High Point, NC United States
  Connect »

Study Site 810

Raleigh, NC United States
  Connect »

Study Site 524

Dublin, OH United States
  Connect »

Study Site 116

Portland, OR United States
  Connect »

Study Site 345

Johnston, RI United States
  Connect »

Study Site 815

Warwick, RI United States
  Connect »

Study Site 805

Nashville, TN United States
  Connect »

Study Site 365

Austin, TX United States
  Connect »

Study Site 120

Dallas, TX United States
  Connect »

Study Site 819

Fort Worth, TX United States
  Connect »

Study Site 359

Pflugerville, TX United States
  Connect »

Study Site 809

San Antonio, TX United States
  Connect »

Study Site 217

Norfolk, VA United States
  Connect »

Study Site 806

Spokane, WA United States
  Connect »

Study Site 812

Walla Walla, WA United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.